{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/magnesium",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736946",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736946_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> (<ph otherprops=\"magnesium aspartate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-aspartate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14090\">magnesium aspartate</xref></ph>, <ph otherprops=\"magnesium glycerophosphate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-glycerophosphate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14092\">magnesium glycerophosphate</xref></ph>, <ph otherprops=\"magnesium hydroxide\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-hydroxide.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP104230\">magnesium hydroxide</xref></ph>, <ph otherprops=\"magnesium sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6120\">magnesium sulfate</xref></ph>)</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  magnesium  ( magnesium aspartate ,  magnesium glycerophosphate ,  magnesium hydroxide ,  magnesium sulfate ) .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alendronic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736947",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736947_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"amlodipine\" outputclass=\"int-drug\">amlodipine</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   amlodipine   (in pregnant women) .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amlodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736948",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736948_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"atracurium\" outputclass=\"int-drug\">atracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   atracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atracurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736949",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736949_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cisatracurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736950",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736950_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"clevidipine\" outputclass=\"int-drug\">clevidipine</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   clevidipine   (in pregnant women) .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clevidipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736951",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736951_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"felodipine\" outputclass=\"int-drug\">felodipine</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   felodipine   (in pregnant women) .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Felodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736952",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736952_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronic acid\" outputclass=\"int-drug\">ibandronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> (<ph otherprops=\"magnesium aspartate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-aspartate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14090\">magnesium aspartate</xref></ph>, <ph otherprops=\"magnesium glycerophosphate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-glycerophosphate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14092\">magnesium glycerophosphate</xref></ph>, <ph otherprops=\"magnesium hydroxide\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-hydroxide.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP104230\">magnesium hydroxide</xref></ph>, <ph otherprops=\"magnesium sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6120\">magnesium sulfate</xref></ph>) for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronic acid\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronic acid</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   is predicted to   decrease   the absorption of   oral   ibandronic acid .  Manufacturer advises avoid  magnesium  ( magnesium aspartate ,  magnesium glycerophosphate ,  magnesium hydroxide ,  magnesium sulfate ) for at least 6 hours before or 1 hour after  ibandronic acid .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ibandronic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736953",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736953_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"lacidipine\" outputclass=\"int-drug\">lacidipine</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   lacidipine   (in pregnant women) .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lacidipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736954",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736954_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"lercanidipine\" outputclass=\"int-drug\">lercanidipine</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   lercanidipine   (in pregnant women) .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lercanidipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736955",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736955_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"mivacurium\" outputclass=\"int-drug\">mivacurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   mivacurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mivacurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736956",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736956_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"nicardipine\" outputclass=\"int-drug\">nicardipine</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   nicardipine   (in pregnant women) .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nicardipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736957",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736957_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"nifedipine\" outputclass=\"int-drug\">nifedipine</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   nifedipine   (in pregnant women) .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nifedipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736958",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736958_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"nimodipine\" outputclass=\"int-drug\">nimodipine</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   nimodipine   (in pregnant women) .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nimodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736959",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736959_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"pancuronium\" outputclass=\"int-drug\">pancuronium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   pancuronium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pancuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736960",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736960_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"risedronate\" outputclass=\"int-drug\">risedronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   decreases   the absorption of   risedronate .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Risedronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736961",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736961_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"rocuronium\" outputclass=\"int-drug\">rocuronium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   rocuronium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rocuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736962",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736962_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"sodium clodronate\" outputclass=\"int-drug\">sodium clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> (<ph otherprops=\"magnesium aspartate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-aspartate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14090\">magnesium aspartate</xref></ph>, <ph otherprops=\"magnesium glycerophosphate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-glycerophosphate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14092\">magnesium glycerophosphate</xref></ph>, <ph otherprops=\"magnesium hydroxide\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-hydroxide.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP104230\">magnesium hydroxide</xref></ph>, <ph otherprops=\"magnesium sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6120\">magnesium sulfate</xref></ph>) for 2 hours before or 1 hour after <ph otherprops=\"sodium clodronate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">sodium clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   decreases   the absorption of   sodium clodronate .  Manufacturer advises avoid  magnesium  ( magnesium aspartate ,  magnesium glycerophosphate ,  magnesium hydroxide ,  magnesium sulfate ) for 2 hours before or 1 hour after  sodium clodronate .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sodium clodronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736963",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736963_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   is predicted to   increase   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Suxamethonium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736964",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1557280736964_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"verapamil\" outputclass=\"int-drug\">verapamil</ph> <ph outputclass=\"int-substanceQualifier\">(in pregnant women)</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   verapamil   (in pregnant women) .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Verapamil</title>"
					}
				}
			],
			"hasSearchLabel": " Magnesium  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/magnesium.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Magnesium </title>"
			},
			"rdfs:label": "magnesium"
		}
	]
}